This post was originally published on Medscape
You will shortly be re-directed to the publisher's website
In patients with T2D who had been hospitalized for poorly controlled blood glucose, SGLT2 inhibitors nearly doubled the risk for falls, and combined use with GLP-1 RAs nearly tripled the risk.
Medscape Medical News